retatrutide type 2 diabetes trial results Efficacy and safety of retatrutide, a GIP, GLP-1, and glucagon receptor agonist, in people with and inadequate glycaemic control with diet and exercise (TRANSCEND-T2D-1): a double-blind, randomised, phase 3 Triple hormone receptor agonist retatrutide

This study has several limitations

You will also need to focus on lifestyle changes, like physical activity and healthy eating

Choosing between them requires understanding not just what each compound does, but how those mechanisms translate into real-world outcomes for different types of researchers

Tirzepatide is not recommended during pregnancy or lactation, and women of reproductive potential should discontinue treatment if pregnancy is recognized

If you give yourself insulin shots, you can inject Ozempic in the same part of your body you use for insulin, such as your abdomen

Improving insulin sensitivity Enhancing metabolic efficiency and reducing fat accumulation